Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology, Women's Studies |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Reproductive |
| Healthy: | No |
| Age Range: | 18 - 71 |
| Updated: | 4/21/2016 |
| Start Date: | August 2011 |
| Contact: | Kan Liu, MD |
| Email: | liuk@upstate.edu |
| Phone: | 315-464-9574 |
The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to
study and compare short/long term change of myocardial perfusion abnormality and cardiac
outcome in diabetic patients after nonfatal MI (heart attack), who are treated with
different glucose control agents.
study and compare short/long term change of myocardial perfusion abnormality and cardiac
outcome in diabetic patients after nonfatal MI (heart attack), who are treated with
different glucose control agents.
Inclusion Criteria:
- Diabetic and nondiabetic patients will be initially recruited and studied after acute
nonfatal MI and revascularization with either PCI or CABG
Exclusion Criteria:
- Patients are excluded if they are older than 70 year old, require mechanical
ventilation, are receiving intravenous pressors or hemodynamic support, or if the
motion of segments associated with infarct-related artery can not be accurately
determined.
We found this trial at
1
site
750 East Adams Street
Syracuse, New York 13210
Syracuse, New York 13210
Principal Investigator: Kan Liu, MD
Phone: 315-464-9574
Click here to add this to my saved trials
